Skip to main content
. 2020 Mar 20;15(3):e0230622. doi: 10.1371/journal.pone.0230622

Table 4. Comparison of KRAS mutation status between matched tissue and plasma samples.

Tissue KRAS mutation Subtotal
Mutant Wild type
ctDNA KRAS mutation
    Mutant 2 0 2
    Wild type 4 30 34
    Subtotal 6 30 36

ctDNA, circulating tumor DNA